IPEC e-newsletter - Excipients Insight April 2017 - 30-04-17

 

Inside this issue

     

IPEC and EXCiPACT take the stage at Making Pharma

Now in its fourth year, Making Pharmaceuticals moved to a new venue (the Ricoh Arena, Coventry) to accommodate their biggest event yet on 25-26 April. More than 110 exhibitors filled a single exhibition space and more than 80 conference sessions were held in four parallel session over the two-day event.

IPEC Europe/EXCiPACT were jointly represented in the exhibition space and met with a steady stream of interested visitors. IPEC Europe hosted a conference session on 25 April. Following a brief introduction about IPEC Europe (Liz Meehan, Board member) presentations were delivered by UK members on three topics: Quality by Design as applied to pharmaceutical excipients (Kevin Hughes, Colorcon), Co-processed excipients (Liz Meehan, AstraZeneca), Pharmacoepial monographs for excipients (Iain Moore, Croda). This session was attended by around 45 visitors.

In the EXCiPACT conference session on 26 April the presentations covered the following areas: Pharmaceutical excipients, putting the “c” into EXCiPACT cGMP and cGDP (Iain Moore), and EU2015 Guidelines on formalised risk assessment for pharmaceutical excipients, how EXCiPACT Certification can help (Tony Scott, EXCiPACT). This session was attended by around 25 visitors.

Enquires at the booth (hosted by IPEC Europe and EXCiPACT) were modest, but very enlightening: almost all had heard of EXCiPACT and many wanted to know more about it. Of particular note was the fact that this included hospital pharmacies who compounded their own drug products, start up pharmaceutical companies and consultants. Clearly the message about EXCiPACT has reached some surprising parts of the industry! There were many opportunities to introduce all visitors to the booth to IPEC Europe and the IPEC activities.

 

 

 

 

Copyright © 2005 - 2017 IPEC Europe - International Pharmaceutical Excipients Council